Literature DB >> 30066284

Lesion correlates of secondary paroxysmal dyskinesia in multiple sclerosis.

Kilian Fröhlich1, Klemens Winder2, Ralf A Linker2, Konstantin Huhn2, Tobias Engelhorn3, Arnd Dörfler3, De-Hyung Lee2, Stefan Schwab2, Frank Seifert2.   

Abstract

Secondary paroxysmal dyskinesia is a rare but life-quality-compromising symptom in multiple sclerosis (MS) and might be associated with particular MS lesions. The present study intended to determine associations between paroxysmal dyskinesia and the MS-associated lesion site using a voxelwise lesion analysis. We conducted a retrospective study and sought MS patients with documented paroxysmal dyskinesia and controls without paroxysmal dyskinesia matched for age, disease severity, and disease duration in a local database. The MS lesions were analysed on T2-weighted magnetic resonance imaging scans (1.5 or 3 T), manually outlined, and transformed into stereotaxic space. We determined the lesion overlap and compared the absence or presence of paroxysmal dyskinesia voxelwise between patients with and without lesions in a given voxel using the Liebermeister test with 4000 permutations. From 15,869 MS patient records screened, we identified 25 patients with paroxysmal dyskinesia. The voxelwise analysis in 22 subjects yielded associations between paroxysmal dyskinesia and MS lesions in the internal capsule, the basal ganglia, and another prominent lesion cluster in the posterior periventricular white matter. Our voxelwise analysis shows associations between paroxysmal dyskinesia and MS lesions in the internal capsule and basal ganglia, areas contributing to motor sequence programming. This association in another lesion site located in the posterior thalamic radiation suggests that lesions in subcortical sensory pathways may also contribute to paroxysmal dyskinesia in MS.

Entities:  

Keywords:  Multiple sclerosis; Paroxysmal dyskinesia; Voxel-based lesion symptom mapping

Mesh:

Year:  2018        PMID: 30066284     DOI: 10.1007/s00415-018-8989-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  41 in total

1.  Paroxysmal attacks in multiple sclerosis.

Authors:  P O Ostermann; C E Westerberg
Journal:  Brain       Date:  1975-06       Impact factor: 13.501

2.  Improving lesion-symptom mapping.

Authors:  Chris Rorden; Hans-Otto Karnath; Leonardo Bonilha
Journal:  J Cogn Neurosci       Date:  2007-07       Impact factor: 3.225

3.  Thalamic demyelination and paroxysmal dystonia in multiple sclerosis.

Authors:  J A Burguera; J Catalá; B Casanova
Journal:  Mov Disord       Date:  1991       Impact factor: 10.338

4.  Paroxysmal dystonia as a rare initial manifestation of multiple sclerosis.

Authors:  Sanem Yilmaz; Gul Serdaroglu; Sarenur Gokben; Hasan Tekgul
Journal:  J Child Neurol       Date:  2011-06-14       Impact factor: 1.987

5.  Tonic "seizures" in a patient with brainstem demyelination: MRI study of brain and spinal cord.

Authors:  M H Libenson; C E Stafstrom; N P Rosman
Journal:  Pediatr Neurol       Date:  1994-10       Impact factor: 3.372

6.  Internal capsule plaque and tonic spasms in multiple sclerosis.

Authors:  D Maimone; A T Reder; F Finocchiaro; E Recupero
Journal:  Arch Neurol       Date:  1991-04

Review 7.  Movement disorders in multiple sclerosis.

Authors:  Patricia K Oakes; Sindhu R Srivatsal; Marie Y Davis; Ali Samii
Journal:  Phys Med Rehabil Clin N Am       Date:  2013-08-27       Impact factor: 1.784

8.  Supratentorial lesions contribute to trigeminal neuralgia in multiple sclerosis.

Authors:  Kilian Fröhlich; Klemens Winder; Ralf A Linker; Tobias Engelhorn; Arnd Dörfler; De-Hyung Lee; Max J Hilz; Stefan Schwab; Frank Seifert
Journal:  Cephalalgia       Date:  2017-10-17       Impact factor: 6.292

9.  Clinical commentary on "Paroxysmal kinesigenic dyskinesia-like phenotype in multiple sclerosis" and "Secondary paroxysmal dyskinesia in multiple sclerosis: Clinical-radiological features and treatment. Case report of seven patients".

Authors:  Isabel Pareés
Journal:  Mult Scler       Date:  2017-04-11       Impact factor: 6.312

10.  Movement disorders in multiple sclerosis: Causal or coincidental association?

Authors:  V Nociti; A R Bentivoglio; G Frisullo; A Fasano; F Soleti; R Iorio; G Loria; A K Patanella; A Marti; T Tartaglione; P A Tonali; A P Batocchi
Journal:  Mult Scler       Date:  2008-09-03       Impact factor: 6.312

View more
  4 in total

Review 1.  Movement Disorders in Multiple Sclerosis: An Update.

Authors:  Ritwik Ghosh; Dipayan Roy; Souvik Dubey; Shambaditya Das; Julián Benito-León
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2022-05-04

Review 2.  Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.

Authors:  Giacomo Garone; Alessandro Capuano; Lorena Travaglini; Federica Graziola; Fabrizia Stregapede; Ginevra Zanni; Federico Vigevano; Enrico Bertini; Francesco Nicita
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 3.  Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in China.

Authors:  Li Cao; Xiaojun Huang; Ning Wang; Zhiying Wu; Cheng Zhang; Weihong Gu; Shuyan Cong; Jianhua Ma; Ling Wei; Yanchun Deng; Qi Fang; Qi Niu; Jin Wang; Zhaoxia Wang; You Yin; Jinyong Tian; Shufen Tian; Hongyan Bi; Hong Jiang; Xiaorong Liu; Yang Lü; Meizhen Sun; Jianjun Wu; Erhe Xu; Tao Chen; Tao Chen; Xu Chen; Wei Li; Shujian Li; Qinghua Li; Xiaonan Song; Ying Tang; Ping Yang; Yun Yang; Min Zhang; Xiong Zhang; Yuhu Zhang; Ruxu Zhang; Yi Ouyang; Jintai Yu; Quanzhong Hu; Qing Ke; Yuanrong Yao; Zhe Zhao; Xiuhe Zhao; Guohua Zhao; Furu Liang; Nan Cheng; Jianhong Han; Rong Peng; Shengdi Chen; Beisha Tang
Journal:  Transl Neurodegener       Date:  2021-02-16       Impact factor: 8.014

4.  Voxel-wise lesion mapping of restless legs syndrome in multiple sclerosis.

Authors:  Kilian Fröhlich; Michael Knott; Stefan Hock; Arnd Dörfler; Frank Seifert; Klemens Winder
Journal:  Neurol Sci       Date:  2022-05-05       Impact factor: 3.830

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.